Skip to content
Hub / Basic Sciences / General Pathology & Immunology
COMLEX Level 1 • 18–22% Blueprint Weight

General Pathology & Immunology

Master high-yield cellular mechanisms, hypersensitivity cascades, immunodeficiency syndromes, transplant immunology, autoantibody diagnostics, and tumor genetics for board examination success.

Gell & Coombs Hypersensitivity Classification

Hypersensitivity reactions represent immunologic tissue damage caused by immune responses against environmental allergens, foreign antigens, or self-antigens. Master the classic mnemonic ACID: Anaphylactic (Type I), Cytotoxic / Cell-bound (Type II), Immune complex (Type III), and Delayed-type T-cell mediated (Type IV).

Immunological Mechanism Architecture

Vector SVG Visualizer
TYPE I: Immediate IgE & Mast Cells Mast Cell Histamine & Tryptase LTC4, LTD4, LTE4 Anaphylaxis • Asthma Timing: Seconds to Mins TYPE II: Cytotoxic Fixed Surface Antigens Target Tissue / RBC IgG / IgM + Complement ADCC (NK cells) • MAC Lysis Goodpasture • AIHA • MG Linear IF on Basement Memb TYPE III: Immune Complex Soluble Ag-Ab Deposits Neutrophil Recruitment C3a, C5a • Fibrinoid Necrosis SLE • PSGN • Serum Sickness Granular "Lumpy-Bumpy" IF TYPE IV: Cell-Mediated NO Antibodies Involved CD4/8 T Mac IFN-γ, TNF-α, Perforin Granulomas • Cytotoxicity Contact Derm • PPD • GVHD Delayed Peak: 48–72 Hours
Type I Immediate: seconds to minutes; Late phase: 2–8 hours

Immediate (Anaphylactic & Atopic)

Key Mediators: IgE, Mast Cells, Basophils

Antigen cross-links preformed IgE bound to high-affinity FcεRI receptors on sensitized mast cells and basophils, triggering immediate degranulation of histamine, tryptase, and proteases. Late-phase response (2–8 hrs) mediated by leukotrienes (LTC4, LTD4, LTE4) and cytokines (IL-4, IL-5, IL-13) driving eosinophil recruitment.

High-Yield Clinical Exemplars

Anaphylaxis Bee stings, peanut allergen, beta-lactam antibiotics

Acute hypotension, laryngeal edema, bronchospasm, urticaria. First-line Rx: IM Epinephrine (1:1000) anterolateral thigh.

Allergic Rhinitis & Conjunctivitis Pollen, dust mites, pet dander

Nasal mucosal edema, eosinophils in nasal discharge, allergic shiners.

Extrinsic (Allergic) Asthma Aeroallergens, fungal spores

Reversible bronchoconstriction, Curschmann spirals (mucus plugs), Charcot-Leyden crystals (eosinophil major basic protein).

Systemic Mastocytosis KIT (CD117) mutation

Excess mast cells in marrow/organs; Darier sign (urticaria with skin rubbing); elevated serum tryptase.

COMLEX Board Trap: COMLEX test-makers love asking for the immediate vs late mediator: Histamine = immediate vasodilation/permeability; Leukotrienes (LTC4/D4/E4) = prolonged bronchoconstriction. Serum Tryptase confirms anaphylaxis degranulation.
Type II Hours to days

Cytotoxic / Antibody-Mediated

Key Mediators: IgG, IgM against cell surface / ECM antigens

Antibodies bind to fixed cell-surface or tissue antigens. Three destructive pathways: (1) Complement activation via classical pathway (C3b opsonization & MAC lysis), (2) Antibody-Dependent Cellular Cytotoxicity (ADCC) via NK cells and macrophages (FcγR), and (3) Receptor dysfunction/stimulation without tissue damage.

High-Yield Clinical Exemplars

Goodpasture Syndrome Autoantibodies vs alpha-3 chain of Type IV collagen

Linear IgG and C3 deposition along glomerular and alveolar basement membranes. Hemoptysis + rapidly progressive glomerulonephritis (RPGN).

Myasthenia Gravis Antibodies against postsynaptic ACh receptors (AChR)

Receptor antagonism/downregulation. Progressive muscle weakness worsening with use, ptosis, diplopia. Associated with thymoma.

Graves Disease Stimulatory antibodies vs TSH receptor (TSI)

Pathway activation independent of TSH. Hyperthyroidism, pretibial myxedema, exophthalmos.

Pemphigus Vulgaris IgG vs Desmoglein 1 and 3 (desmosomes)

Flaccid intraepidermal bullae, tombstone stratum basale, oral mucosal ulcers, (+) Nikolsky sign. Reticular / fishnet IF pattern.

Bullous Pemphigoid IgG vs BP180 / BP230 (hemidesmosomes)

Tense subepidermal bullae, spares oral mucosa, (-) Nikolsky sign. Linear IgG along dermal-epidermal junction.

Autoimmune Hemolytic Anemia (AIHA) Warm (IgG, extravascular/spleen) vs Cold (IgM, intravascular/liver)

Direct Coombs test (+). Warm AIHA: SLE, CLL; Cold AIHA: Mycoplasma pneumoniae, EBV mononucleosis.

Hyperacute Transplant Rejection Preformed recipient IgG vs donor HLA/ABO

Occurs within minutes of unclamping graft vessels. Thrombotic occlusion, graft ischemia/necrosis.

COMLEX Board Trap: Mnemonic: "2 = Cy-two-toxic / Tissue-specific". Notice: Pemphigus is Flaccid with fishnet; Pemphigoid is Tense with linear line. Goodpasture is Linear (Type II) while PSGN is Granular "lumpy bumpy" (Type III).
Type III 1 to 3 weeks post-exposure (or 4–10 hrs for local Arthus)

Immune Complex-Mediated

Key Mediators: Soluble Antigen-Antibody (IgG/IgM) Complexes + Complement

Circulating soluble antigen-antibody complexes form in slight antigen excess, escape reticuloendothelial clearance, and deposit in vascular basement membranes (renal glomeruli, synovia, dermal vessels). Complexes fix complement, releasing C3a and C5a (anaphylatoxins and neutrophil chemoattractants). Infiltrating neutrophils release lysosomal enzymes and ROS, producing fibrinoid necrosis.

High-Yield Clinical Exemplars

Systemic Lupus Erythematosus (SLE) Nuclear antigens + Anti-dsDNA / Anti-Sm

Lupus nephritis (diffuse proliferative GN with subendothelial wire-loop deposits), low C3/C4 levels, rash, arthritis.

Poststreptococcal Glomerulonephritis (PSGN) GAS nephritogenic antigens (SPEB)

2–4 weeks post-pharyngitis or impetigo. Granular "lumpy-bumpy" subepithelial humps on EM; cola-colored urine, low C3.

Serum Sickness Foreign protein (chimeric monoclonal antibodies, antivenom, rabies Ig)

7–14 days post-exposure. Triad: Fever, urticaria/rash, arthralgias + lymphadenopathy and proteinuria. Low serum complement.

Polyarteritis Nodosa (PAN) Immune complexes (30% associated with Hepatitis B)

Transmural necrotizing inflammation of medium-sized arteries with fibrinoid necrosis; "string-of-pearls" microaneurysms on angiogram.

Arthus Reaction Intradermal antigen injection in presensitized host with high circulating IgG

Local subacute immune complex deposition, dermal vessel thrombosis, and local tissue necrosis (e.g., booster tetanus vaccine).

COMLEX Board Trap: Serum sickness vs Type I: Serum sickness takes 1-2 WEEKS because it takes time for IgG antibodies to be produced and form complexes. Key lab: LOW C3 and C4 due to massive complement consumption!
Type IV 48 to 72 hours (delayed)

Cell-Mediated (Delayed-Type / T-Cell)

Key Mediators: Sensitized T-Lymphocytes (CD4+ Th1/Th17 & CD8+ CTLs) — NO ANTIBODIES

Two distinct pathways: (1) Delayed-Type Hypersensitivity (DTH): Antigen presented by APCs on MHC II to CD4+ Th1 cells. Th1 cells release IFN-γ, which potently activates macrophages to secrete TNF-α and form granulomas. (2) Direct Cytotoxicity: CD8+ CTLs recognize foreign or modified intracellular antigens on MHC I and induce target cell apoptosis via perforin, granzyme B, and FasL.

High-Yield Clinical Exemplars

Contact Dermatitis Urushiol (poison ivy/oak), nickel, topical neomycin, cosmetics

Pruritic erythematous papules and vesicles arranged in linear distributions corresponding to contact; spongiosis on biopsy.

Tuberculin Skin Test (PPD) Purified protein derivative of M. tuberculosis

Induration measured at 48–72 hours. Mediated by memory Th1 cells and recruited macrophages releasing TNF-α and IFN-γ.

Graft-versus-Host Disease (GVHD) Donor T cells in allogeneic bone marrow graft attack recipient HLA

Maculopapular rash (palms/soles), cholestatic jaundice (bile duct destruction), severe watery diarrhea.

Acute Cellular Transplant Rejection Recipient CD8+ T cells recognize donor MHC I

Weeks to months post-transplant. Dense interstitial lymphocytic infiltrate with tubulitis/endothelialitis. Responsive to steroids.

Multiple Sclerosis & Guillain-Barré Myelin basic protein / peripheral myelin targeting

Autoimmune demyelination mediated by T-cells and macrophage infiltration.

COMLEX Board Trap: Mnemonic: The 4 Ts of Type IV: T cells, Transplant rejection (acute/chronic cellular), TB skin test, Touching (contact dermatitis). Crucial: Type IV does NOT involve antibodies or complement!